10.04.2019 • News

Arlanxeo Appoints Donald Chen as Chief Executive Officer

Arlanxeo appointed Donald Chen as new chief executive officer (CEO) Source:...
Arlanxeo appointed Donald Chen as new chief executive officer (CEO) Source: Arlanxeo

Arlanxeo appointed Donald Chen as new chief executive officer (CEO) with effect from May 1, 2019. He succeeds Jorge Nogueira, who is retiring after a career spanning nearly 40 years in the chemical and pharmaceutical industry.

"With Donald Chen we have an experienced leader and industry expert joining the company. He has spent many years of his working life in the Asia-Pacific region, a key growth region for Arlanxeo,” said Abdulaziz M. Al-Judaimi, chairman of the Arlanxeo shareholders' committee and Saudi Aramco's senior vice president of Downstream.

Chen joins Arlanxeo from Archer Daniels Midland (ADM), where he was responsible for operations in the Asia-Pacific region, including Australia and New Zealand, since January 2016 and was also a member of the Executive Council of ADM. He previously held various leadership positions at Sadara, Dow Chemical and Royal Dutch Shell. Chen has a master's degree in engineering and a doctorate from Delft University of Technology in the Netherlands.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read